Cargando…

A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder

Detalles Bibliográficos
Autores principales:	Frye, Richard E, Rose, Shannon, Boles, Richard G., Rossignol, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877244/ https://www.ncbi.nlm.nih.gov/pubmed/35207636 http://dx.doi.org/10.3390/jpm12020147

Ejemplares similares

A Personalized Multidisciplinary Approach to Evaluating and Treating Autism Spectrum Disorder
por: Frye, Richard E.
Publicado: (2022)

Synchrony 2022: Epilepsy and Seizures in Autism Spectrum Disorder Roundtable
por: Frye, Richard E., et al.
Publicado: (2023)

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
por: Rose, Shannon, et al.
Publicado: (2018)

Synchrony 2022: The Role of Neuroinflammation in Behavioral Exacerbations in Autism Spectrum Disorder
por: Frankovich, Jennifer, et al.
Publicado: (2023)

Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
por: Frye, Richard Eugene, et al.
Publicado: (2014)

Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes
por: Frye, Richard E., et al.
Publicado: (2016)

The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review
por: Rossignol, Daniel A., et al.
Publicado: (2014)

The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021)

Metabolomic Signatures of Autism Spectrum Disorder
por: Brister, Danielle, et al.
Publicado: (2022)

Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders
por: Nanda, Heer, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
por: Rossignol, Daniel A, et al.
Publicado: (2021)

Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment
por: Jyonouchi, Harumi, et al.
Publicado: (2022)

Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2020)

Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021)

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome
por: Frye, Richard E., et al.
Publicado: (2015)

Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey
por: Adams, James B., et al.
Publicado: (2021)

Environmental toxicants and autism spectrum disorders: a systematic review
por: Rossignol, D A, et al.
Publicado: (2014)

Age-Related Changes in Epilepsy Characteristics and Response to Antiepileptic Treatment in Autism Spectrum Disorders
por: Gundogdu, Beliz Su, et al.
Publicado: (2023)

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
por: Rossignol, D A, et al.
Publicado: (2012)

Hyperbaric oxygen treatment in autism spectrum disorders
por: Rossignol, Daniel A, et al.
Publicado: (2012)

Cerebral folate receptor autoantibodies in autism spectrum disorder
por: Frye, R E, et al.
Publicado: (2013)

Mitochondria May Mediate Prenatal Environmental Influences in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2021)

The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment
por: Frye, Richard E., et al.
Publicado: (2022)

Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141
por: Rossignol, Daniel A., et al.
Publicado: (2022)

Editorial: Comorbidity and Autism Spectrum Disorder
por: Casanova, Manuel F., et al.
Publicado: (2020)

Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder
por: Frye, Richard E
Publicado: (2014)

Variations in Mitochondrial Respiration Differ in IL-1ß/IL-10 Ratio Based Subgroups in Autism Spectrum Disorders
por: Jyonouchi, Harumi, et al.
Publicado: (2019)

Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD)
por: Harville, Terry, et al.
Publicado: (2019)

MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
por: Frye, Richard E., et al.
Publicado: (2021)

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
por: Rossignol, D A, et al.
Publicado: (2012)

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism
por: Rossignol, Daniel A., et al.
Publicado: (2014)

The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder
por: Indika, Neluwa-Liyanage R., et al.
Publicado: (2023)

Microbiota and Autism Spectrum Disorder
por: Akhondzadeh, Shahin
Publicado: (2019)

The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder
por: Delhey, Leanna M., et al.
Publicado: (2017)

Mitochondrial morphology is associated with respiratory chain uncoupling in autism spectrum disorder
por: Frye, Richard E., et al.
Publicado: (2021)

Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents
por: Frye, Richard E.
Publicado: (2018)

Early life metal exposure dysregulates cellular bioenergetics in children with regressive autism spectrum disorder
por: Frye, Richard E., et al.
Publicado: (2020)

Modern Biomarkers for Autism Spectrum Disorder: Future Directions
por: Jensen, Amanda R., et al.
Publicado: (2022)

Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
por: Frye, Richard E., et al.
Publicado: (2016)

Air Pollution and Maximum Temperature Are Associated with Neurodevelopmental Regressive Events in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3a7p0st4lo8irc4r9292tkvq82